Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Pregabalin Trial In HIV Neuropathic Pain

ClinicalTrials.gov ID: NCT01145417

Public ClinicalTrials.gov record NCT01145417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 8:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study examines the safety of pregabalin over a 6 month period in patients with neuropathic pain associated with HIV infection as an extension of another trial that tests the efficacy of pregabalin.

Study identification

NCT ID
NCT01145417
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
217 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2010
Primary completion
Apr 30, 2012
Completion
Apr 30, 2012
Last update posted
Jan 27, 2021

2010 – 2012

United States locations

U.S. sites
10
U.S. states
4
U.S. cities
7
Facility City State ZIP Site status
Southwest Center for HIV/AIDS Phoenix Arizona 85006
Arizona Research Center Phoenix Arizona 85023
Providence Clinical Research Burbank California 91505
Desert Medical Group, Inc., dba Desert Oasis Healthcare Medical Group Palm Springs California 92262
Desert Medical Group, Inc., dba Desert Oasis Helathcare Medical Group Palm Springs California 92262
University of California San Diego San Diego California 92103
Stanford University Medical Center Stanford California 94305
Neuroscience Consultants, LLC Aventura Florida 33180
South Florida Medical Research Aventura Florida 33180
Mount Sinai School of Medicine New York New York 10029

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

Recently updated HIV-1 Infection trials

Other public records listing HIV-1 Infection. Sorted by last update posted; newest first. Not a recommendation.

All HIV-1 Infection trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01145417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2021 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01145417 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →